Benchling

Benchling is a biotechnology startup founded in 2012, headquartered in the United States. The company's slogan, "On a mission to unlock the power of biotechnology and empower our global customers to get to milestones & market faster," encapsulates its vision. Benchling aims to facilitate the advancement of biotechnology, recognizing its impact on various facets of life, from medicine to agriculture and materials. Driven by the need for better technology to match the new speed of science, Benchling provides the R&D Cloud utilized by the world's most innovative biotech companies. This platform powers the development of breakthrough products and accelerates time to milestone and market. Benchling's recent significant achievement was a $100.00M Series F investment received on 17th November 2021. The investors in this round included Franklin Templeton Venture Capital, Lone Pine Capital, and Altimeter Capital. The company's invitation to "help us bring modern software to modern science" conveys its commitment to advancing the biotechnology sector. Benchling's focus on empowering its global customers and driving the biotech industry forward demonstrates its potential for growth and impact. With its recent substantial investment and support from notable venture capital firms, Benchling is poised to continue making strides in revolutionizing biotechnology. For individuals interested in joining the company, career opportunities can be explored on their website.